Adri M Galvan

7PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsOther creative arts and writing not elsewhere classifiedMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2025
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy.

Adnan Fazili, Seyed Behzad Jazayeri, Kyle M Rose

|Mar 04, 2025
Repeat TURBT in large volume high-grade non-invasive bladder cancer.

Adri M Durant, Mimi Nguyen, Mouneeb M Choudry

|Jun 11, 2024
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study.

Mouneeb M Choudry, Adri M Durant, Victoria S Edmonds

|Dec 20, 2023
Reply by Authors.

Mark D Tyson, Robert Abouassaly, Adri Durant

|Nov 01, 2023
Budgetary Impact of Including the Urinary Genomic Marker Cxbladder Detect in the Evaluation of Microhematuria Patients.

Mark D Tyson, Robert Abouassaly, Adri Durant

|Jul 22, 2022
Salvage versus primary holmium laser enucleation of the prostate: trends, outcomes and safety analysis.

Adri M Durant, Jonathan Moore, Sandeep Voleti

Pageof 2

Frequent Collaborators

1 joint publications

Adnan Fazili

1 joint publications

Seyed Behzad Jazayeri

1 joint publications

Roger Li